Cover image of the article: Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi’an, China

Image Credit:Hepat Mon

Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi’an, China

Authors

wei xiaoli1, Wang Lirong1, Wang Xueliang1,*, Li Jinsong2, Li Hengxin2, Jia Wei3
1Department of Epidemiology and Biostatistics, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, China
2Xi’an Center for Disease Control and Prevention, Xi’an, China
3Methadone Maintenance Therapy Clinic, Xi’an Mental Health Center, Xi’an, China
*Corresponding Author: Department of Epidemiology and Biostatistics, School of Public Health, Xi’an Jiaotong University Health Science Center, Xi’an, China. Tel: +86-2982655108, Fax: +86-2982655103, E-mail: wangxl@mail.xjtu.edu.cn. Email: wangxl@mail.xjtu.edu.cn

Hepatitis Monthly:Vol. 14, issue 11; e93072
Published online:Nov 23, 2014
Article type:Research Article
Received:May 06, 2019
Accepted:Nov 08, 2014
How to Cite:xiaoli W, Lirong W, Xueliang W, Jinsong L, Hengxin L, et al. Risk Factors of Hepatitis C Virus Infection in Drug Users From Eleven Methadone Maintenance Treatment Clinics in Xi’an, China. Hepat Mon. 2014;14(11):e93072. doi: https://doi.org/10.5812/hepatmon.19601

Abstract

Background: Hepatitis C virus (HCV) infection rates in drug users vary among different regions of China. Drug users who are unaware of their HCV serostatus tend to engage in more risky behaviors.

Objectives: This prospective study aimed to assess risk factors of HCV infection in drug users among 11 methadone maintenance treatment (MMT) clinics in Xi’an, China.

Patients and Methods: Baseline characteristics and drug use information of patients were collected upon enrollment in the study and anti-HCV tests were performed within one month after the enrollment. Data on daily medication, monthly random urine morphine test results, illicit drug use and MMT retention time were recorded during a 5-year follow-up.

Results: Of 10243 patients, 58.0% had positive results for anti-HCV. Injection drug use, longer duration of drug abuse, older age, female gender, unmarried status and unemployment were independent risk factors of HCV infection. Urine test positivity rate was lower (14.8% vs. 16.7%, χ2 = 100.235, P < 0.05), but MMT retention rate was higher (log-rank χ2 = 4.397, P < 0.05) in the anti-HCV positive group than anti-HCV negative one. However, multivariate regression revealed no significant association between anti-HCV serostatus and either MMT retention time or illicit drug use.

Conclusions: The major risk factor of HCV infection was injection drug use. The patient’s awareness of his or her HCV status had a minor effect in reduction of illicit drug use and improvement in MMT retention. Therefore, adequate counseling is necessary for drug users in MMT clinics in Xi’an.

Highlights

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2014, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

24
Mar
2020
Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China

Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China

Dangui Zhang,
Xubin Zhang,
Lu Xu,
D. Lorne Tyrrell,
Michael Houghton,
William Ba-Thein

Zhang D, Zhang X, Xu L, Tyrrell DL, Houghton M, et al. Seroepidemiology of Hepatitis C Among Drug Users at a Detoxification Center in Southeast China. Hepat Mon. 2020;20(3):e99249. doi: https://doi.org/10.5812/hepatmon.99249

17
Aug
2013
Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

Seyed-Moayed Alavian,
Alireza Mirahmadizadeh,
Mehdi Javanbakht,
Ali Keshtkaran,
Alireza Heidari,
Atefeh Mashayekhi
,et al.

Alavian S, Mirahmadizadeh A, Javanbakht M, Keshtkaran A, Heidari A, et al. Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users. Hepat Mon. 2013;13(8):e12411. doi: https://doi.org/10.5812/hepatmon.12411

27
Mar
2016
Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients

Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients

Hamid Abousaeedi,
Omid Reza Hosseini,
Reza Bidaki,
Mahmood Sheikh Fathollahi,
Hamid Reza Goodarzi Nejad,
Golam Hossein Hassan Shahi
,et al.

Abousaeedi H, Reza Hosseini O, Bidaki R, Sheikh Fathollahi M, Goodarzi Nejad HR, et al. Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients. Thrita J Neu. 2016;5(4):e36365. doi: https://doi.org/10.5812/thrita.36365

25
Oct
2017
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

Asaad Sharhani,
Yadollah Mehrabi,
Alireza Noroozi,
Maryam Nasirian,
Peter Higgs,
Ahmad Hajebi
,et al.

Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, et al. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon. 2017;17(10):e58739. doi: https://doi.org/10.5812/hepatmon.58739

28
Apr
2018
Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

Arash Alaei,
Kathryn Mishkin,
Saifuddin Karimov,
Dilshod Saidi,
Kamiar Alaei

Alaei A, Mishkin K, Karimov S, Saidi D, Alaei K. Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan. Hepat Mon. 2018;18(3):e64860. doi: https://doi.org/10.5812/hepatmon.64860

More by these authors

wei xiaoliPubMedScholar
Wang LirongPubMedScholar
Wang XueliangPubMedScholar
Li JinsongPubMedScholar
Li HengxinPubMedScholar
Share
Cited by
Metrics